From: Minimax and admissible adaptive two-stage designs in phase II clinical trials
Interval of q | n | ESS0 | Comment |
---|---|---|---|
[0.000,0.040] | 60 | 34.08 | Optimal design |
[0.040,0.105] | 59 | 34.12 | |
[0.105,0.132] | 57 | 34.36 | |
[0.132,0.468] | 54 | 34.81 | |
[0.468,0.580] | 53 | 35.69 | |
[0.580,0.721] | 51 | 38.45 | |
[0.721,1.000] | 50 | 41.03 | Minimax design |